Skip to main content
. 2019 Sep 24;11:1758835919874651. doi: 10.1177/1758835919874651

Figure 7.

Figure 7.

LINC01419 combined with Rapamycin downregulates the expressions of MMP2 and VEGF. (a) Expression of MMP2 in the presence of LINC01419 siRNA, Rapamycin, or both. (b) Expression of VEGF in the presence of LINC01419 siRNA, Rapamycin, or both; *p < 0.05 versus the NC group; #p < 0.05 versus the Rapamycin group; measurement data were presented as mean ± standard deviation and compared by one-way ANOVA followed by Tukey’s post hoc test; the experiment was repeated three times.

ANOVA, one-way analysis of variance; GC, gastric cancer; mTOR, mammalian target of rapamycin; NC, negative control; siRNAs, small interfering RNAs.